FDA is soliciting general comments on GDUFA II Program Fee: List of Abbreviated New Drug Application Sponsors and Application Numbers. The information gathered from public comments will assist FDA in accurately assessing FY 2018 GDUFA Program Fees in a timely manner.
Similar Posts
Kuka Flex Forte contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Kuka Flex Forte, a product promoted and sold for joint pain and arthritis on various websites, including https://botanical-be.com, and possibly in some retail stores.Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs
This guidance recommends approaches that sponsors of clinical trials intended to support a new drug application or a biologics license application can take to increase enrollment of a representative population in their clinical trials.Mr. Strong Guy Honey For Him contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Mr. Strong Guy Honey For Him, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Online Controlled Substances Summits
FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the public, including youth, from harm associated with drugs that have abuse potential.Pharmaceutical Quality Resources
FDA provides resources on pharmaceutical quality topics, including information on regulations, guidance documents, and compliance programs.A2A integrated Logistics Inc – 02/24/2025
A2A integrated Logistics Inc – 02/24/2025. Country: United States. Record Type: 483